Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000936392-04-000319
Filing Date
2004-03-30
Accepted
2004-03-30 15:17:05
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AM. #1 TO FORM 10-K YEAR ENDED 12-31-03 a97675a1e10vkza.htm 10-K/A 794314
3 EXHIBIT 10.47 a97675a1exv10w47.txt EX-10.47 7875
4 EXHIBIT 14.1 a97675a1exv14w1.txt EX-14.1 8808
5 EXHIBIT 23.1 a97675a1exv23w1.txt EX-23.1 816
6 EXHIBIT 31.1 a97675a1exv31w1.txt EX-31.1 3494
7 EXHIBIT 31.2 a97675a1exv31w2.txt EX-31.2 3623
8 EXHIBIT 32.1 a97675a1exv32w1.txt EX-32.1 1486
  Complete submission text file 0000936392-04-000319.txt   822731
Mailing Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-860-2500
EPIMMUNE INC (Filer) CIK: 0000822206 (see all company filings)

EIN.: 330245076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19591 | Film No.: 04700527
SIC: 2834 Pharmaceutical Preparations